GI ASC market not deterred by COVID-19, could hit $10.27B by 2027

The U.S. gastroenterology ASC market was worth $7.21 billion in 2019 and is expected to grow at a compound annual growth rate of 5.8 percent through 2027 to hit $10.27 billion, according to a Reports Globe report.

Leading companies in the market include:

  • Olympus
  • Johnson & Johnson
  • Medtronic
  • GE Healthcare
  • Boston Scientific
  • Cardinal Health

The majority of centers are either affiliated with a hospital, freestanding or physician-owned.

More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers